Summary
Biogen Inc. (BIIB) filed an 8-K on April 24, 2019, primarily to report its first-quarter 2019 financial results. The company issued a press release detailing its financial performance for the period ended March 31, 2019. While the 8-K itself does not contain the detailed financial figures, it incorporates by reference Biogen's press release (Exhibit 99.1), which serves as the primary source of information for investors regarding the quarterly results. Investors should refer to Exhibit 99.1 for specific details on revenue, earnings per share, and other key financial metrics for the first quarter of 2019. This filing signals the company's adherence to timely reporting requirements for material financial events and provides stakeholders with an update on the company's operational and financial condition.
Key Highlights
- 1Biogen Inc. (BIIB) announced its first-quarter 2019 financial results via a press release.
- 2The 8-K filing incorporates the press release (Exhibit 99.1) by reference.
- 3The filing is dated April 24, 2019, covering the period ended March 31, 2019.
- 4Investors need to consult Exhibit 99.1 for the actual financial performance data.
- 5This is a standard disclosure for earnings releases.
- 6The information furnished is not deemed 'filed' for purposes of Section 18 of the Exchange Act.